Consolidated Balance Sheets - USD ($) $ in Thousands	Oct. 02, 2021	Oct. 03, 2020
Current assets:
Cash and cash equivalents	$ 650,026	$ 480,526
Accounts receivable, net of allowances of approximately $7 million and $9 million as of October 2, 2021 and October 3, 2020, respectively	1,192,434	1,043,334
Contract assets	348,741	396,583
Inventories	1,036,511	861,281
Prepaid expenses and other current assets	53,952	37,718
Total current assets	3,281,664	2,819,442
Property, plant and equipment, net	532,985	559,242
Deferred income tax assets, net	235,117	273,470
Other	156,953	120,502
Total assets	4,206,719	3,772,656
Current liabilities:
Accounts payable	1,464,693	1,210,049
Accrued liabilities	161,896	171,761
Accrued payroll and related benefits	117,648	122,029
Short-term debt, including current portion of long-term debt	18,750	18,750
Total current liabilities	1,762,987	1,522,589
Long-term liabilities:
Long-term debt	311,572	329,249
Other	253,532	290,902
Total long-term liabilities	565,104	620,151
Commitments and Contingencies (Note 10)
Stockholders' equity:
Preferred stock, $0.01 par value, authorized 5,000 shares, none issued and outstanding	0	0
Common stock, $0.01 par value, authorized 166,667 shares; 108,734 and 107,629 shares issued and 64,307 and 64,999 shares outstanding as of October 2, 2021 and October 3, 2020, respectively	643	650
Treasury stock, 44,427 and 42,630 shares as of October 2, 2021 and October 3, 2020, respectively, at cost	(1,047,202)	(983,143)
Additional paid-in capital	6,338,863	6,300,887
Accumulated other comprehensive income	40,690	34,886
Accumulated deficit	(3,454,366)	(3,723,364)
Total stockholders' equity	1,878,628	1,629,916
Total liabilities and stockholders' equity	$ 4,206,719	$ 3,772,656